Introduction
============

Stroke is a significant worldwide problem. An estimated 80% of the patients survive for at least 1 year after stroke, yet \>70% have enduring disabilities.[@b1-cia-13-1709],[@b2-cia-13-1709] Ischemic stroke (IS) and intracerebral hemorrhage account for \~80%--85% and 15%--20% of all stroke cases, respectively.[@b3-cia-13-1709] IS is a complex syndrome whose pathological development involves multiple components, which include environmental and genetic factors.[@b4-cia-13-1709] Established environmental risk factors include age, sex, body mass index, hypertension, diabetes mellitus, smoking, and hyperlipidemia. However, recent studies suggested that genetics may contribute more than environment to IS, considering that a number of single-gene disorders are related to IS.[@b5-cia-13-1709]--[@b8-cia-13-1709] Nevertheless, the factors defining genetic susceptibility to IS remain unclear.

MicroRNAs (miRNAs) represent a group of short non-coding RNA molecules, 18--25 nucleotides in length. Bioinformatics data indicate that a single miRNA can bind to as many as 200 gene targets, and miRNAs may regulate the expression of approximately one-third of protein-coding mRNAs. A single-nucleotide polymorphism (SNP) in miRNA may create a mismatch, leading to gene expression disorder and diseases.[@b9-cia-13-1709] Evidence has indicated that miRNAs regulate various IS-related biological processes, such as atherosclerosis, hypertension, and plaque rupture.[@b10-cia-13-1709] In fact, altered miRNA expression has been observed in IS in preclinical animal models and patients, suggesting a potential role in predicting the diagnosis and prognosis of IS.[@b11-cia-13-1709],[@b12-cia-13-1709]

More specifically, the literature suggests an association between IS and polymorphisms in miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), and miR-499 (rs3746444).[@b13-cia-13-1709]--[@b26-cia-13-1709] However, these associations are controversial because individual studies relied on relatively small samples. Therefore, to obtain a more comprehensive understanding of the available evidence, we conducted this meta-analysis of 14 case--control studies to evaluate the possible association between IS risk and miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), and miR-499 (rs3746444) in Asian populations.

Materials and methods
=====================

Search strategy
---------------

All clinical and experimental case--control studies of miRNA polymorphisms and IS risk published through February 1, 2018 were identified through systematic searches in PubMed, EMBASE, Google Scholar, and the Chinese National Knowledge Infrastructure (CNKI) databases using English and Chinese. The search terms used were as follows: microRNA; miRNA; these two terms in combination with polymorphism, polymorphisms, SNP, variant, variants, variation, genotype, genetic, or mutation; and all the above-mentioned terms in combination with stroke or ischemic stroke. Reference lists in identified articles and reviews were also searched manually to identify additional eligible studies.

Inclusion criteria
------------------

To be included in our review and meta-analysis, studies had to 1) have a case--control design for assessing the association of IS risk with miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), and miR-499 (rs3746444); 2) be accessible as a full-text article and report sufficient data for estimating ORs with 95% CIs; 3) report genotype frequencies; and 4) involve humans rather than animal models.

Data extraction
---------------

Two authors (DHZ and CBL) independently extracted the following data from the included studies: first author's family name, year of publication, ethnicity, testing methods, control source, age, sex, *P*-value for Hardy--Weinberg equilibrium (HWE) in controls, numbers and genotypes of cases and controls, and frequencies of genotypes in cases and controls. Discrepancies were resolved by consensus. Only those studies that met the predetermined inclusion criteria were included.

Assessment of methodological quality
------------------------------------

To assess the quality of the studies included in this analysis, the Newcastle--Ottawa scale was used by two independent assessors (JRW and LC).[@b27-cia-13-1709] For the Newcastle--Ottawa scale, a full score is nine stars; a score range of 5--9 stars is considered to indicate generally high methodological quality, whereas a range of 0--4 stars is considered to indicate poor quality.[@b28-cia-13-1709] The quality of all the included studies is summarized in [Table 1](#t1-cia-13-1709){ref-type="table"}. Any disagreements about Newcastle--Ottawa scores were resolved by other authors following a comprehensive reassessment. Only high-quality studies were included in our meta-analysis.

Statistical analyses
--------------------

The unadjusted OR with 95% CI was used to assess the strength of the association of IS risk with miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), and miR-499 (rs3746444) based on genotype frequencies in cases and controls. The significance of pooled ORs was determined using the *Z*-test, with *P*\<0.05 defined as the significance threshold. Meta-analysis was conducted using a fixed-effect model when *P*\>0.10 for the *Q*-test, indicating the lack of heterogeneity among studies; otherwise, a random-effect model was used. All these statistical tests were performed using Review Manager 5.2 (Cochrane Collaboration, Oxford, England).

Publication bias was assessed using Begg's funnel plot and Egger's weighted regression, with *P*\<0.05 considered statistically significant. Begg's funnel plots and Egger's weighted regression were calculated using Stata 12.0 (StataCorp LP, College Station, TX, USA).

Results
=======

Description of studies
----------------------

[Figure 1](#f1-cia-13-1709){ref-type="fig"} is a flow diagram illustrating the process of searching for and selecting studies. A total of 184 potentially relevant publications up to February 1, 2018 were systematically identified through searches of the PubMed, EMBASE, Google Scholar, and CNKI databases in English and Chinese. Of these, we excluded 161 studies during initial screening based on review of the titles and abstracts. During analysis of the full text of the remaining articles, two studies were excluded for not being case--control studies, three studies were excluded because they did not report precise genotypes, and two articles were excluded because they investigated polymorphisms of miRNAs other than miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), or miR-499 (rs3746444). A further two studies were excluded because they were not written in English or Chinese.

In the end, 14 studies[@b13-cia-13-1709]--[@b26-cia-13-1709] were included in this meta-analysis based on our search strategy and inclusion criteria. Their characteristics are summarized in [Table 2](#t2-cia-13-1709){ref-type="table"}. Of these, 13 studies[@b13-cia-13-1709],[@b14-cia-13-1709],[@b16-cia-13-1709]--[@b26-cia-13-1709] ([Table 3](#t3-cia-13-1709){ref-type="table"}) involving 5,726 cases and 7,175 controls evaluated the association between miR-146a (rs2910164) polymorphism and IS risk. Seven studies[@b16-cia-13-1709],[@b18-cia-13-1709]--[@b20-cia-13-1709], [@b24-cia-13-1709]--[@b26-cia-13-1709] ([Table 3](#t3-cia-13-1709){ref-type="table"}) involving 3,090 cases and 3,047 controls evaluated the association between miR-196a2 (rs11614913) polymorphism and IS risk. Six studies[@b15-cia-13-1709]--[@b17-cia-13-1709],[@b24-cia-13-1709]--[@b26-cia-13-1709] ([Table 3](#t3-cia-13-1709){ref-type="table"}) involving 2,448 cases and 2,322 controls evaluated miR-149 (rs2292832) polymorphism and IS risk. The remaining seven studies[@b16-cia-13-1709],[@b18-cia-13-1709],[@b20-cia-13-1709],[@b23-cia-13-1709]--[@b26-cia-13-1709] ([Table 3](#t3-cia-13-1709){ref-type="table"}) involving 3,082 cases and 3,044 controls evaluated miR-499 (rs3746444) polymorphism and IS risk. The distribution of genotypes in controls was consistent with HWE (*P*\>0.05) in all but three studies.[@b14-cia-13-1709],[@b20-cia-13-1709],[@b22-cia-13-1709] The overall quality of the included studies was adequate, and the mean Newcastle--Ottawa score for the included studies was 6.57 ([Table 1](#t1-cia-13-1709){ref-type="table"}).

Quantitative data synthesis
---------------------------

### IS risk and miR-146a (rs2910164) polymorphism

The overall results for miR-146a (rs2910164) are summarized in [Table 4](#t4-cia-13-1709){ref-type="table"} and [Figure 2](#f2-cia-13-1709){ref-type="fig"}. On the basis of 5,726 cases and 7,175 controls from 13 studies,[@b13-cia-13-1709],[@b14-cia-13-1709],[@b16-cia-13-1709]--[@b26-cia-13-1709] the overall results indicated that the GG genotype of miR-146a (rs2910164) may be associated with increased IS risk according to the recessive model (OR=1.20, 95% CI=1.02--1.42, *P*=0.03; [Figure 2B](#f2-cia-13-1709){ref-type="fig"}).

IS risk and miR-196a2 (rs11614913) polymorphism
-----------------------------------------------

The overall results are summarized in [Table 4](#t4-cia-13-1709){ref-type="table"} and [Figure 3](#f3-cia-13-1709){ref-type="fig"}. On the basis of 3,090 cases and 3,047 controls from seven studies,[@b16-cia-13-1709],[@b18-cia-13-1709]--[@b20-cia-13-1709],[@b24-cia-13-1709]--[@b26-cia-13-1709] miR-196a2 (rs11614913) polymorphism did not show significant association with IS risk in any of the following five genetic models: allelic model, OR=1.04, 95% CI=0.97--1.12, *P*=0.27 ([Figure 3A](#f3-cia-13-1709){ref-type="fig"}); recessive model, OR=1.04, 95% CI=0.93--1.17, *P*=0.46 ([Figure 3B](#f3-cia-13-1709){ref-type="fig"}); dominant model, OR=0.95, 95% CI=0.85--1.08, *P*=0.44 ([Figure 3C](#f3-cia-13-1709){ref-type="fig"}); homozygous model, OR=0.95, 95% CI=0.85--1.08, *P*=0.44 ([Figure 3D](#f3-cia-13-1709){ref-type="fig"}); and heterozygous model, OR=1.07, 95% CI=0.93--1.23, *P*=0.37 ([Figure 3E](#f3-cia-13-1709){ref-type="fig"}).

IS risk and miR-149 (rs2292832) polymorphism
--------------------------------------------

The overall results for miR-149 (rs2292832) are summarized in [Table 4](#t4-cia-13-1709){ref-type="table"} and [Figure 4](#f4-cia-13-1709){ref-type="fig"}. On the basis of 2,448 cases and 2,322 controls from six studies,[@b16-cia-13-1709],[@b18-cia-13-1709],[@b20-cia-13-1709],[@b23-cia-13-1709]--[@b26-cia-13-1709] the overall results indicated that the CC genotype of miR-149 (rs2292832) may be associated with increased IS risk according to the recessive model (OR=1.28, 95% CI=1.08--1.52, *P*=0.005; [Figure 4B](#f4-cia-13-1709){ref-type="fig"}) and homozygous model (OR=1.31, 95% CI=1.09--1.58, *P*=0.004; [Figure 4D](#f4-cia-13-1709){ref-type="fig"}).

IS risk and miR-499 (rs3746444) polymorphism
--------------------------------------------

The overall results are summarized in [Table 4](#t4-cia-13-1709){ref-type="table"} and [Figure 5](#f5-cia-13-1709){ref-type="fig"}. On the basis of 3,082 cases and 3,044 controls from seven studies,[@b16-cia-13-1709],[@b18-cia-13-1709],[@b20-cia-13-1709],[@b23-cia-13-1709]--[@b26-cia-13-1709] miR-499 (rs3746444) polymorphism did not show significant association with IS risk in any of the following five genetic models: allelic model, OR=1.09, 95% CI=0.95--1.25, *P*=0.20 ([Figure 5A](#f5-cia-13-1709){ref-type="fig"}); recessive model, OR=1.21, 95% CI=0.91--1.61, *P*=0.19 ([Figure 5B](#f5-cia-13-1709){ref-type="fig"}); dominant model, OR=0.93, 95% CI=0.78--1.12, *P*=0.44 ([Figure 5C](#f5-cia-13-1709){ref-type="fig"}); homozygous model, OR=1.20, 95% CI=0.90--1.60, *P*=0.21 ([Figure 5D](#f5-cia-13-1709){ref-type="fig"}); or heterozygous model, OR=1.06, 95% CI=0.87--1.28, *P*=0.57 ([Figure 5E](#f5-cia-13-1709){ref-type="fig"}).

Sensitivity analysis
--------------------

Sensitivity analysis was conducted for miR-146a (rs2910164) by excluding the studies by Li et al[@b14-cia-13-1709] and Qu et al;[@b22-cia-13-1709] the *P*-value for HWE was less than 0.05 for these two studies. The recessive model gave different results (OR=1.19, 95% CI=0.98--1.45, *P*=0.07) than those obtained when all studies were meta-analyzed. Sensitivity analysis was conducted for miR-146a (rs2910164) by excluding one study by Jeon et al.[@b16-cia-13-1709] Again, the recessive model gave different results (OR=1.18, 95% CI=0.99--1.41, *P*=0.07) than when all studies were included. Therefore, the results for miR-146a (rs2910164) should be interpreted with caution.

Sensitivity analysis was conducted for miR-196a2 (rs11614913) by excluding the study by Jeon et al.[@b16-cia-13-1709] The results were similar to those obtained with all studies, regardless of the genetic model. This implies that our meta-analysis results for miR-196a2 (rs11614913) are robust. Similar robustness was observed when we performed sensitivity analysis for miR-149 (rs2292832) and for miR-499 (rs3746444) by excluding the study by Jeon et al.[@b16-cia-13-1709]

Sensitivity analysis was conducted for miR-499 (rs3746444) by excluding a study by Huang et al,[@b20-cia-13-1709] in which the *P*-value of HWE was less than 0.05. The results were not altered in any of the five genetic models.

Publication bias
----------------

Begg's funnel plot and Egger's test were performed to detect potential publication bias in this meta-analysis. No obvious asymmetry was observed in Begg's funnel plots in the recessive model, and Egger's tests ([Figure 6](#f6-cia-13-1709){ref-type="fig"}) indicated no publication bias.

Discussion
==========

Previous studies have demonstrated that mutations in the pre-miRNA of miR-146a, miR-499, miR-149, and miR-196a2 decrease the levels of the corresponding mature miRNAs.[@b20-cia-13-1709],[@b29-cia-13-1709],[@b30-cia-13-1709] These four miRNAs affect thrombosis or inflammation pathways in the circulatory system by regulating tumor necrosis factor-α (TNF-α),[@b31-cia-13-1709] methylenetetrahydrofolate reductase,[@b32-cia-13-1709] annexin A1,[@b33-cia-13-1709] C-reactive protein,[@b34-cia-13-1709] the NF-κB pathway, and the MAP kinase pathway.[@b35-cia-13-1709] Many studies have been conducted to reveal the impact of SNPs on precursor and mature miRNAs and their associations with IS risk.[@b13-cia-13-1709]--[@b26-cia-13-1709] In fact, several meta-analyses have been conducted to explore the association between miRNA polymorphisms and IS risk. The results have been inconsistent, largely due to limited sample size.[@b36-cia-13-1709]--[@b39-cia-13-1709] Therefore, we conducted this meta-analysis on all eligible studies to provide a more precise estimate of the association of IS risk with miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), and miR-499 (rs3746444). Interestingly, all the case--control studies in our meta-analysis analyzed Asian populations.

A previous meta-analysis by Zhu et al[@b39-cia-13-1709] found the C allele of miR-146a (rs2910164) to be associated with lower IS risk, but this trend was observed only in Koreans according to the allelic model. Our meta-analysis, in contrast, suggests that this C allele is not significantly associated with IS risk; instead, we found the GG genotype of miR-146a (rs2910164) to be associated with increased risk. Our result may be more reliable than that of the previous meta-analysis by Zhu et al[@b39-cia-13-1709] because our meta-analysis contained nine more case--control studies[@b14-cia-13-1709],[@b15-cia-13-1709],[@b17-cia-13-1709],[@b21-cia-13-1709]--[@b26-cia-13-1709] with larger samples. Our subgroup analysis suggesting a significant relationship between the C allele of miR-146a (rs2910164) and lower IS risk contained only one case--control study, which was by Jeon et al.[@b16-cia-13-1709]

While the meta-analysis by Zhu et al[@b39-cia-13-1709] reported an association between the A allele of miR-499 (rs3746444) and decreased IS risk in Chinese, our meta-analysis did not detect this association, either across Asian populations or specifically in the Chinese population (data not shown). Our result may be more reliable because our meta-analysis included four more case--control studies[@b23-cia-13-1709]--[@b26-cia-13-1709] than the one by Zhu et al.[@b39-cia-13-1709] The results of our meta-analysis are consistent with those reported in the meta-analysis by Xiao et al.[@b37-cia-13-1709]

Our meta-analysis suggests a significant association between the CC genotype of miR-149 (rs2292832) and increased IS risk. In contrast, the meta-analysis of Xiao et al[@b37-cia-13-1709] based on two case--control studies indicated that the TT genotype and T allele of miR-149 (rs2292832) are associated with significantly lower IS risk, whereas another meta-analysis[@b36-cia-13-1709] based on three case--control studies found the CC genotype and C allele of miR-149 (rs2292832) to be significantly associated with IS risk. Our meta-analysis contained three more case--control studies[@b24-cia-13-1709]--[@b26-cia-13-1709] than either of these other meta-analyses, which may make it more reliable.

Our meta-analysis did not find a significant association between miR-196a2 (rs11614913) polymorphism and IS risk. This result confirms other meta-analyses[@b37-cia-13-1709]--[@b39-cia-13-1709] based on smaller samples.

To the best of our knowledge, the current meta-analysis involves the largest sample (6,083 cases and 7,248 controls) than previous studies[@b36-cia-13-1709]--[@b39-cia-13-1709] investigating the possible association of IS risk with miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), and miR-499 (rs3746444) in Asian populations. Nevertheless, the meta-analysis is limited by the designs of the included studies. First, the *P*-value for HWE was less than 0.05 in two studies[@b14-cia-13-1709],[@b22-cia-13-1709] on miR-146a (rs2910164) and one study[@b26-cia-13-1709] on miR-499 (rs3746444). These results suggested that these study populations may not be representative of the broader target population. Second, the results may be affected by both genetic and environmental factors, but most studies did not report environmental exposure, making it impossible to include them in the meta-analysis. Third, our exclusion of unpublished data and of papers published in languages other than English and Chinese may have biased our results. Fourth, the studies may be subject to performance bias, attrition bias, and reporting bias, although Newcastle--Ottawa scores were at least 5 for all 14 studies, indicating high quality. Fifth, stroke is a heterogeneous disease and has different subtypes that may affect the results of genetic association studies, but most case--control studies in our meta-analysis appeared not to use a well-phenotyped population. This may make the results less accurate. Finally, all the patients in this meta-analysis were Asian and this may limit the relevance of the results to other populations. Thus, more large and well-designed studies are warranted in non-Asian populations.

Conclusion
==========

This meta-analysis suggests that the GG genotype of miR-146a (rs2910164) and the CC genotype of miR-149 (rs2292832) may confer increased susceptibility to IS in Asian populations, whereas polymorphism in miR-196a2 (rs11614913) and miR-499 (rs3746444) may not be associated with IS risk. These conclusions should be verified in large and well-designed studies.
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###### 

Forest plot describing the association between the miR-146a (rs2910164) polymorphism and ischemic stroke risk according to different genetic models: (**A**) allelic (G-allele vs C-allele), (**B**) recessive (GG vs GC+CC), (**C**) dominant (CC vs GC+GG), (**D**) homozygous (GG vs CC), and (**E**) heterozygous (GC vs CC).
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###### 

Forest plot describing the association between the miR-196a2 (rs11614913) polymorphism and ischemic stroke risk according to different genetic models: (**A**) allelic, (**B**) recessive, (**C**) dominant, (**D**) homozygous, and (**E**) heterozygous.
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###### 

Forest plot describing the association between the miR-149 (rs2292832) polymorphism and ischemic stroke risk according to different genetic models: (**A**) allelic, (**B**) recessive, (**C**) dominant, (**D**) homozygous, and (**E**) heterozygous.
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###### 

Forest plot describing the association between the miR-149 (rs2292832) polymorphism and ischemic stroke risk according to different genetic models: (**A**) allelic, (**B**) recessive, (**C**) dominant, (**D**) homozygous, and (**E**) heterozygous.
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###### 

Begg's funnel plot and Egger's test to assess publication bias in the meta-analysis of potential associations between ischemic stroke risk and (**A** and **B**) miR-146a (rs2910164), (**C** and **D**) miR-196a2 (rs11614913), (**E** and **F**) miR-149 (rs2292832), and (**G** and **H**) miR-499 (rs3746444).

**Note:** All analyses were performed using a recessive genetic model.
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###### 

Methodological quality of the studies included in the final analysis based on the Newcastle--Ottawa scale for assessing the quality of case--control studies

  Study                           Selection (score)   Comparability (score)   Exposure (score)   Total score[b](#tfn2-cia-13-1709){ref-type="table-fn"}                   
  ------------------------------- ------------------- ----------------------- ------------------ -------------------------------------------------------- --- --- --- --- ---
  Sun[@b13-cia-13-1709]           1                   1                       0                  1                                                        2   0   1   1   7
  Li[@b14-cia-13-1709]            1                   1                       0                  1                                                        0   0   1   1   5
  He and Han[@b15-cia-13-1709]    1                   1                       0                  1                                                        2   0   1   1   7
  Jeon et al[@b16-cia-13-1709]    1                   1                       0                  1                                                        2   0   1   1   7
  Hu et al[@b17-cia-13-1709]      1                   1                       0                  1                                                        2   0   1   1   7
  Liu et al[@b18-cia-13-1709]     1                   1                       0                  1                                                        1   0   1   1   6
  Zhu et al[@b19-cia-13-1709]     1                   1                       0                  1                                                        2   0   1   1   7
  Huang et al[@b20-cia-13-1709]   1                   1                       0                  1                                                        2   0   1   1   7
  Zhong et al[@b21-cia-13-1709]   1                   1                       0                  1                                                        2   0   1   1   7
  Qu et al[@b22-cia-13-1709]      1                   1                       0                  1                                                        0   0   1   1   5
  Lyu et al[@b23-cia-13-1709]     1                   1                       0                  1                                                        2   0   1   1   7
  Zhu[@b24-cia-13-1709]           1                   1                       0                  1                                                        2   0   1   1   7
  Luo et al[@b25-cia-13-1709]     1                   1                       0                  1                                                        2   0   1   1   7
  Zhu et al[@b26-cia-13-1709]     1                   1                       0                  1                                                        2   0   1   0   6

**Notes:**

When there was no significant difference in the response rate between both groups based on a chi-squared test (*P*\>0.05), one point was awarded.

Total score was calculated by adding up the points awarded in each item.

###### 

Characteristics of the studies included in the meta-analysis

  Study                           Year   Ethnicity   Country       Testing method   Control source                      Age (years, mean ±SD)                                    Male, n (%)                                              SNP                         
  ------------------------------- ------ ----------- ------------- ---------------- ----------------------------------- -------------------------------------------------------- -------------------------------------------------------- ------------- ------------- --------------------------------------------------------------------------------------------
  Sun[@b13-cia-13-1709]           2011   Asian       China         PCR-RFLP         Hospital-based healthy volunteers   63±12                                                    62±13                                                    236 (61.9)    347 (53.4)    miR-146a
  Li[@b14-cia-13-1709]            2010   Asian       China         PCR-RFLP         Hospital-based healthy volunteers   64±11                                                    45±12                                                    188 (67.2)    579 (57.3)    miR-146a
  He and Han[@b15-cia-13-1709]    2013   Asian       China         PCR-RFLP         Hospital-based healthy volunteers   65.7±11.5                                                66.3±10.2                                                205 (55.0)    193 (51.7)    miR-149
  Jeon et al[@b16-cia-13-1709]    2013   Asian       South Korea   TaqMan           Hospital-based healthy volunteers   64.16±11.90                                              63.14±10.19                                              336 (49.6)    244 (44.1)    miR-146a miR-149 (rs2292832); and miR-499 (rs3746444)
  Hu et al[@b17-cia-13-1709]      2014   Asian       China         PCR-RFLP         Hospital-based healthy volunteers   64±11.7                                                  63±10.5                                                  94 (48.0)     95 (46.3)     miR-146a (rs2910164) and miR-149 (rs2292832)
  Liu et al[@b18-cia-13-1709]     2014   Asian       China         PCR-RFLP         Hospital-based healthy volunteers   67.52±10.29                                              66.34±11.07                                              227 (58.06)   180 (60.81)   miR-146a (rs2910164); miR-196a2 (rs11614913); and miR-499 (rs3746444)
  Huang et al[@b20-cia-13-1709]   2015   Asian       China         TaqMan           Hospital-based healthy volunteers   63 (54--70)[a](#tfn3-cia-13-1709){ref-type="table-fn"}   61 (54--68)[a](#tfn3-cia-13-1709){ref-type="table-fn"}   327 (61.6)    327 (61.6)    miR-146a (rs2910164); miR-196a2 (rs11614913); and miR-499 (rs3746444)
  Zhong et al[@b21-cia-13-1709]   2016   Asian       China         PCR              Hospital-based healthy volunteers   62.6±8.63                                                61.1±9.58                                                177 (59.6)    170 (56.7)    miR-146a (rs2910164)
  Qu et al[@b22-cia-13-1709]      2016   Asian       China         PCR-LDR          Hospital-based healthy volunteers   61.30±9.40                                               59.50±8.50                                               718 (63.0)    903 (57.0)    miR-146a (rs2910164)
  Lyu et al[@b23-cia-13-1709]     2016   Asian       China         TaqMan           Hospital-based healthy volunteers   58±11.9                                                  58±11.9                                                  210 (55.6)    210 (55.6)    miR-146a (rs2910164) and miR-499 (rs3746444)
  Zhu[@b24-cia-13-1709]           2016   Asian       China         PCR-RFLP         Hospital-based healthy volunteers   63.74±4.49                                               63.31±4.84                                               215 (54.3)    202 (53.4)    miR-146a (rs2910164); miR-196a2 (rs11614913); miR-149 (rs2292832); and miR-499 (rs3746444)
  Luo et al[@b25-cia-13-1709]     2017   Asian       China         PCR              Hospital-based healthy volunteers   67.70±12.33                                              60.17±10.32                                              196 (65.8)    181 (59.8)    miR-146a (rs2910164); miR-196a2 (rs11614913); miR-149 (rs2292832); and miR-499 (rs3746444)
  Zhu et al[@b26-cia-13-1709]     2017   Asian       China         TaqMan           Hospital-based healthy volunteers   61.0±10.2                                                59.7±9.9                                                 321 (62.9)    311 (59.4)    miR-146a (rs2910164); miR-196a2 (rs11614913); miR-149 (rs2292832); and miR-499 (rs3746444)

**Note:**

These data are expressed as median (25th, 75th quartiles).

**Abbreviations:** LDR, ligase detection reaction; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; SNP, single-nucleotide polymorphism.

###### 

Genotype distributions of miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), and miR-499 (rs3746444)

  Study                           Year     *P*-value for HWE   Sample size (cases/controls)   No of cases   Allele frequencies of cases, n (%)   No of controls   Allele frequencies of controls, n (%)                                                     
  ------------------------------- -------- ------------------- ------------------------------ ------------- ------------------------------------ ---------------- --------------------------------------- ------------ ------- ------- ----- -------------- --------------
  Sun[@b13-cia-13-1709]           2011     0.345               358/650                        136           161                                  61               433 (60.5)                              283 (39.5)   228     304     118   760 (58.5)     540 (41.5)
  Li[@b14-cia-13-1709]            2010     0.009               268/1,010                      79            110                                  79               268 (50.0)                              268 (50.0)   345     455     210   1,145 (56.7)   875 (43.3)
  Jeon et al[@b16-cia-13-1709]    2013     0.589               678/553                        223           327                                  128              773 (57.0)                              583 (43.0)   211     266     76    688 (62.2)     418 (37.8)
  Hu et al[@b17-cia-13-1709]      2014     0.193               196/205                        75            87                                   34               237 (60.5)                              155 (39.5)   97      82      26    276 (67.3)     134 (32.7)
  Liu et al[@b18-cia-13-1709]     2014     0.650               296/391                        85            159                                  52               329 (55.6)                              263 (44.4)   116     198     77    430 (55.0)     352 (45.0)
  Zhu et al[@b19-cia-13-1709]     2014     0.952               368/381                        145           173                                  50               463 (63.0)                              273 (37.0)   132     185     64    449 (80.6)     313 (19.4)
  Huang et al[@b20-cia-13-1709]   2015     0.106               531/531                        189           261                                  81               639 (60.2)                              423 (39.8)   219     257     55    695 (65.4)     367 (34.6)
  Zhong et al[@b21-cia-13-1709]   2016     0.133               297/300                        141           128                                  28               410 (69.0)                              184 (31.0)   113     152     35    378 (63.0)     222 (37.0)
  Qu et al[@b22-cia-13-1709]      2016     \<0.001             1,139/1,585                    355           618                                  166              1,328 (58.3)                            950 (41.7)   483     869     233   1,835 (57.9)   1,335 (42.1)
  Lyu et al[@b23-cia-13-1709]     2016     0.079               378/378                        119           198                                  61               436 (57.7)                              320 (42.3)   153     187     38    493 (65.2)     263 (34.8)
  Zhu[@b24-cia-13-1709]           2016     0.521               396/378                        131           194                                  71               456 (57.6)                              336 (42.4)   154     179     45    487 (64.4)     269 (35.6)
  Luo et al[@b25-cia-13-1709]     2017     0.672               298/303                        129           130                                  39               388 (65.1)                              208 (34.9)   119     139     45    377 (62.2)     229 (37.8)
  Zhu et al[@b26-cia-13-1709]     2017     0.085               523/510                        170           267                                  86               607 (58.0)                              439 (42.0)   204     251     55    659 (64.6)     361 (35.4)
                                                                                                                                                                                                                                                            
  **miR-196a2 (rs11614913)**      **TT**   **TC**              **CC**                         **T**         **C**                                **TT**           **TC**                                  **CC**       **T**   **C**                        
                                                                                                                                                                                                                                                            
  Jeon et al[@b16-cia-13-1709]    2013     0.126               678/553                        139           352                                  187              630 (46.5)                              726 (53.5)   105     292     156   502 (45.4)     604 (54.6)
  Liu et al[@b18-cia-13-1709]     2014     0.060               296/391                        51            181                                  64               283 (47.8)                              309 (52.2)   84      214     93    382 (48.8)     400 (51.2)
  Zhu et al[@b19-cia-13-1709]     2014     0.384               368/381                        71            189                                  108              331 (45.0)                              405 (55.0)   78      198     105   354 (46.5)     408 (53.5)
  Huang et al[@b20-cia-13-1709]   2015     0.856               531/531                        100           265                                  166              465 (43.8)                              597 (56.2)   112     266     153   490 (46.1)     572 (53.9)
  Zhu[@b24-cia-13-1709]           2016     0.354               396/378                        112           205                                  79               429 (54.2)                              363 (45.8)   110     196     72    416 (55.0)     340 (45.0)
  Luo et al[@b25-cia-13-1709]     2017     0.385               298/303                        73            138                                  87               284 (47.7)                              312 (52.3)   75      159     69    309 (51.0)     297 (49.0)
  Zhu et al[@b26-cia-13-1709]     2017     0.548               523/510                        150           273                                  100              573 (54.8)                              473 (45.2)   146     260     104   552 (54.1)     468 (45.9)
                                                                                                                                                                                                                                                            
  **miR-149 (rs2292832)**         **TT**   **TC**              **CC**                         **T**         **C**                                **TT**           **TC**                                  **CC**       **T**   **C**                        
                                                                                                                                                                                                                                                            
  He and Han[@b15-cia-13-1709]    2013     0.303               357/373                        138           162                                  57               438 (66.6)                              276 (41.4)   160     175     38    495 (66.4)     251 (33.6)
  Jeon et al[@b16-cia-13-1709]    2013     0.921               678/553                        299           303                                  76               901 (66.4)                              455 (33.6)   262     238     53    762 (68.9)     344 (31.1)
  Hu et al[@b17-cia-13-1709]      2014     0.199               196/205                        79            76                                   41               234 (59.7)                              158 (40.3)   80      89      36    249 (60.7)     161 (39.3)
  Zhu[@b24-cia-13-1709]           2016     0.720               396/378                        165           179                                  52               509 (64.3)                              283 (35.7)   190     158     30    538 (71.2)     218 (28.8)
  Luo et al[@b25-cia-13-1709]     2017     0.447               298/303                        131           127                                  40               389 (65.3)                              207 (34.7)   121     136     46    378 (62.4)     228 (37.6)
  Zhu et al[@b26-cia-13-1709]     2017     0.351               523/510                        232           221                                  70               685 (65.5)                              361 (34.5)   240     213     57    693 (67.9)     327 (32.1)
                                                                                                                                                                                                                                                            
  **miR-499 (rs3746444)**         **AA**   **AG**              **GG**                         **A**         **G**                                **AA**           **AG**                                  **GG**       **A**   **G**                        
                                                                                                                                                                                                                                                            
  Jeon et al[@b16-cia-13-1709]    2013     0.740               678/553                        460           195                                  23               1,115 (82.2)                            241 (17.8)   365     170     18    900 (81.4)     206 (18.6)
  Liu et al[@b18-cia-13-1709]     2014     0.170               296/391                        181           96                                   19               458 (77.4)                              134 (22.6)   278     99      14    655 (83.8)     127 (16.2)
  Huang et al[@b20-cia-13-1709]   2015     0.002               531/531                        398           133                                  0                929 (87.5)                              133 (12.5)   403     128     0     934 (87.9)     128 (12.1)
  Lyu et al[@b23-cia-13-1709]     2016     0.621               378/378                        257           110                                  11               624 (82.5)                              132 (17.5)   250     113     15    613 (81.1)     143 (18.9)
  Zhu[@b24-cia-13-1709]           2016     0.910               396/378                        255           123                                  18               633 (79.9)                              159 (20.1)   249     116     13    614 (81.2)     142 (18.8)
  Luo et al[@b25-cia-13-1709]     2017     0.131               298/303                        215           78                                   5                508 (85.2)                              88 (14.8)    244     53      6     541 (89.3)     65 (10.7)
  Zhu et al[@b26-cia-13-1709]     2017     0.380               505/510                        349           124                                  32               840 (80.3)                              206 (19.7)   328     158     24    814 (79.8)     206 (20.2)

**Abbreviation:** HWE, Hardy--Weinberg equilibrium.

###### 

Overall meta-analysis of the association between ischemic stroke and polymorphisms in miR-146a (rs2910164), miR-196a2 (rs11614913), miR-149 (rs2292832), and miR-499 (rs3746444)

  Genetic model                                                                          OR \[95% CI\]         Z (*P*-value)   Heterogeneity of study design   Analysis model        
  -------------------------------------------------------------------------------------- --------------------- --------------- ------------------------------- ---------------- ---- --------
  miR-146a (rs2910164) from 13 case--control studies (5,726 cases and 7,175 controls)                                                                                                
   Allelic model (G-allele vs C-allele)                                                  1.10 \[0.99--1.22\]   1.74 (0.08)     47.91                           12 (\<0.001)     75   Random
   Recessive model (GG vs GC+CC)                                                         1.20 \[1.02--1.42\]   2.16 (0.03)     31.55                           12 (0.002)       62   Random
   Dominant model (CC vs GC+GG)                                                          0.91 \[0.80--1.04\]   1.41 (0.16)     34.76                           12 (\<0.001)     65   Random
   Homozygous model (GG vs CC)                                                           1.24 \[1.00--1.53\]   1.95 (0.05)     43.43                           12 (\<0.001)     72   Random
   Heterozygous model (GC vs CC)                                                         1.06 \[0.95--1.17\]   1.00 (0.32)     20.79                           12 (0.05)        42   Random
  miR-196a2 (rs11614913) from 7 case--control studies (3,090 cases and 3,047 controls)                                                                                               
   Allelic model (C-allele vs T-allele)                                                  1.04 \[0.97--1.12\]   1.10 (0.27)     3.20                            6 (0.78)         0    Fixed
   Recessive model (CC vs TC+TT)                                                         1.04 \[0.93--1.17\]   0.73 (0.46)     4.60                            6 (0.60)         0    Fixed
   Dominant model (TT vs TC+CC)                                                          0.95 \[0.85--1.08\]   0.77 (0.44)     2.86                            6 (0.83)         0    Fixed
   Homozygous model (CC vs TT)                                                           1.07 \[0.92--1.24\]   0.91 (0.36)     2.85                            6 (0.83)         0    Fixed
   Heterozygous model (TC vs TT)                                                         1.07 \[0.93--1.23\]   0.90 (0.37)     2.72                            5 (0.74)         0    Fixed
  miR-149 (rs2292832) from 6 case--control studies (2,448 cases and 2,322 controls)                                                                                                  
   Allelic model (C-allele vs T-allele)                                                  1.09 \[1.00--1.18\]   1.91 (0.06)     4.84                            5 (0.44)         0    Fixed
   Recessive model (CC vs TC+TT)                                                         1.28 \[1.08--1.52\]   2.80 (0.005)    6.14                            5 (0.29)         19   Fixed
   Dominant model (TT vs TC+CC)                                                          0.89 \[0.79--1.00\]   1.99 (0.05)     6.31                            5 (0.28)         21   Fixed
   Homozygous model (CC vs TT)                                                           1,31 \[1.09--1.58\]   2.92 (0.004)    8.27                            5 (0.14)         40   Fixed
   Heterozygous model (TC vs TT)                                                         1.07 \[0.95--1.21\]   1.12 (0.26)     4.22                            5 (0.52)         0    Fixed
  miR-499 (rs3746444) from 7 case--control studies (3,082 cases and 3,044 controls)                                                                                                  
   Allelic model (G-allele vs A-allele)                                                  1.09 \[0.95--1.25\]   1.28 (0.20)     12.36                           6 (0.05)         51   Random
   Recessive model (GG vs AG+AA)                                                         1.21 \[0.91--1.61\]   1.31 (0.19)     3.81                            5 (0.58)         0    Fixed
   Dominant model (AA vs AG+GG)                                                          0.93 \[0.78--1.12\]   0.77 (0.44)     16.43                           6 (0.01)         63   Random
   Homozygous model (GG vs AA)                                                           1.20 \[0.90--1.60\]   1.25 (0.21)     4.47                            5 (0.48)         0    Fixed
   Heterozygous model (AG vs AA)                                                         1.06 \[0.87--1.28\]   0.56 (0.57)     17.10                           6 (0.009)        65   Random

[^1]: These authors contributed equally to this work
